Reactor seeks licence renewal

McMaster’s teaching and research nuclear reactor is seeking a renewal of its operating licence. As part of the standard operating procedure, the reactor’s licence must be renewed by the Canadian Nuclear Safety Commission on a regular basis.

McMaster’s reactor is used for research purposes in several areas including engineering and medical physics and for commercial purposes. It is one of the world’s largest suppliers of the medical radioisotope iodine-125, used for the treatment of prostate cancer.

In addition to the numerous faculty members and graduate students who make use of the reactor for research, several undergraduate courses have laboratory components that involve the nuclear reactor and associated facilities. Since its launch in 1959, the reactor has provided training for students in the form of summer internships, laboratory and isotope production technicians, and engineering assistants.

A licence renewal hearing is scheduled for May 8 in Ottawa. Members of the public who have an interest or expertise in the reactor are invited to comment on the application. You can learn more by visiting: nuclearsafety.gc.ca

Republish this Article for Free

Republish this Article

We believe in the free flow of information. This work is licensed under a Creative Commons Attribution-No Derivs 2.5 Canada (CC BY-ND 2.5 CA), so you can republish our articles for free, online or in print.

All republished articles must be attributed in the following way and contain links to both the site and original article: “This article was first published on Daily News. Read the original article.”

McMaster’s teaching and research nuclear reactor is seeking a renewal of its operating licence. As part of the standard operating procedure, the reactor’s licence must be renewed by the Canadian Nuclear Safety Commission on a regular basis.

McMaster’s reactor is used for research purposes in several areas including engineering and medical physics and for commercial purposes. It is one of the world’s largest suppliers of the medical radioisotope iodine-125, used for the treatment of prostate cancer.

In addition to the numerous faculty members and graduate students who make use of the reactor for research, several undergraduate courses have laboratory components that involve the nuclear reactor and associated facilities. Since its launch in 1959, the reactor has provided training for students in the form of summer internships, laboratory and isotope production technicians, and engineering assistants.

A licence renewal hearing is scheduled for May 8 in Ottawa. Members of the public who have an interest or expertise in the reactor are invited to comment on the application. You can learn more by visiting: nuclearsafety.gc.ca

Media Enquiries

Phone: (905) 525-9140 ext. 24073
Email: comms@mcmaster.ca

The Communications and Public Affairs Office is staffed from 8:30 a.m. to 4:30 p.m. Monday to Friday.

The University has a broadcast quality television studio to facilitate live and pre-recorded interviews with media. Learn more about our experts.